Cytokinetics CYTK Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on trailing twelve months.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's interest coverage?
- Cytokinetics (CYTK) reported interest coverage of -12.5× in Q1 2026.
- How has Cytokinetics's interest coverage changed year-over-year?
- Cytokinetics's interest coverage increased by 12.8% year-over-year, from -14.3× to -12.5×.
- What is the long-term trend for Cytokinetics's interest coverage?
- Over 5 years (2020 to 2025), Cytokinetics's interest coverage has grown at a 17.9% compound annual growth rate (CAGR), from -5.9× to -13.4×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.